Loading...
Loading...
India's tacrolimus imports from CROATIA total $38.4K across 17 shipments from 1 foreign suppliers. PLIVA CROATIA LTD. leads with $38.4K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include WATSON PHARMA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for tacrolimus — a concentrated sourcing relationship with select suppliers from CROATIA.

PLIVA CROATIA LTD. is the leading Tacrolimus supplier from CROATIA to India, with import value of $38.4K across 17 shipments. The top 5 suppliers — PLIVA CROATIA LTD. — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PLIVA CROATIA LTD. | $38.4K | 17 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | WATSON PHARMA PRIVATE LIMITED | $38.4K | 17 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Tacrolimus suppliers from CROATIA to India include PLIVA CROATIA LTD.. The leading supplier is PLIVA CROATIA LTD. with import value of $38.4K USD across 17 shipments. India imported Tacrolimus worth $38.4K USD from CROATIA in total across 17 shipments.
India imported Tacrolimus worth $38.4K USD from CROATIA across 17 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Tacrolimus sourced from CROATIA include WATSON PHARMA PRIVATE LIMITED. The largest buyer is WATSON PHARMA PRIVATE LIMITED with $38.4K in imports across 17 shipments.
The total value of Tacrolimus imports from CROATIA to India is $38.4K USD, across 17 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
17 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists